Replies to post #29626 on RUMORED NEWS, NEWS and STOCKS GOINGUP

[elks]

BOARD MARKED HERE and already have you member marked....:)

[BottomBounce]

$DNDN. PROVENGE® (sipuleucel-T) is approved by the FDA as an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer. http://www.provenge.com/